Around 1 in 10 babies are in need of some form of stabilisation at birth. The heart rate of the baby is critical for guiding the stabilisation or resuscitation process; however current monitoring methods do not always provide an early enough or sometimes an accurate enough heart rate. This can lead to uncertainty in the management of the baby’s care.
What we do
Accurate, rapid measurements benefit clinical staff by enabling them to make confident decisions more quickly and to focus on performing procedures in time critical situations.
SurePulse may help reduce the time patients spend in neonatal intensive care and reduce costs for healthcare organisations.
Babies born in Europe every year need some form of resuscitation
Learn moreWhat this means
About one in ten babies need some form of help in the first few minutes after birth to stimulate breathing and to ensure the heart is beating properly. That adds up to a staggering 80,000 babies in the UK, more than 200 each day, and 14 million worldwide each year.
Learn more
Delighted to be the runner up in the national start up awards. Congrats to winners Verti! #MedTechExpo #medilink
Surepulse up for the start up award at tonight's Medilink UK awards ceremony. Wish us luck!
We are very excited for the Medilink UK Healthcare Business Awards 2019 🏆
This year's event takes place 15 May and will celebrate all the innovative breakthroughs made across the #lifesciences & #healthtech sectors in the last year.
Book your tickets: https://t.co/QzqYnjBrbk
Keynote speaker at the @UniofNottingham Enterprise Dinner @MPayton_Mercia of @MerciaTech - ‘We’re backing the regions and we’re backing SMEs’ @UoNresearch @UoNBusiness @JessicaCorner @andyn5678
